These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 21087463

  • 1. Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial).
    Everitt HA, Moss-Morris RE, Sibelli A, Tapp L, Coleman NS, Yardley L, Smith PW, Little PS.
    BMC Gastroenterol; 2010 Nov 18; 10():136. PubMed ID: 21087463
    [Abstract] [Full Text] [Related]

  • 2. Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website.
    Everitt H, Moss-Morris R, Sibelli A, Tapp L, Coleman N, Yardley L, Smith P, Little P.
    BMC Gastroenterol; 2013 Apr 21; 13():68. PubMed ID: 23602047
    [Abstract] [Full Text] [Related]

  • 3. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H, Landau S, Little P, Bishop FL, O'Reilly G, Sibelli A, Holland R, Hughes S, Windgassen S, McCrone P, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.
    Health Technol Assess; 2019 Apr 21; 23(17):1-154. PubMed ID: 31042143
    [Abstract] [Full Text] [Related]

  • 4. Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults.
    Everitt H, Landau S, Little P, Bishop FL, McCrone P, O'Reilly G, Coleman N, Logan R, Chalder T, Moss-Morris R, ACTIB trial team.
    BMJ Open; 2015 Jul 15; 5(7):e008622. PubMed ID: 26179651
    [Abstract] [Full Text] [Related]

  • 5. Exploring patients' views of a cognitive behavioral therapy-based website for the self-management of irritable bowel syndrome symptoms.
    Tonkin-Crine S, Bishop FL, Ellis M, Moss-Morris R, Everitt H.
    J Med Internet Res; 2013 Sep 03; 15(9):e190. PubMed ID: 24001787
    [Abstract] [Full Text] [Related]

  • 6. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.
    Kennedy TM, Chalder T, McCrone P, Darnley S, Knapp M, Jones RH, Wessely S.
    Health Technol Assess; 2006 Jun 03; 10(19):iii-iv, ix-x, 1-67. PubMed ID: 16729918
    [Abstract] [Full Text] [Related]

  • 7. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial.
    Everitt HA, Landau S, O'Reilly G, Sibelli A, Hughes S, Windgassen S, Holland R, Little P, McCrone P, Bishop FL, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.
    Lancet Gastroenterol Hepatol; 2019 Nov 03; 4(11):863-872. PubMed ID: 31492643
    [Abstract] [Full Text] [Related]

  • 8. Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care.
    Reme SE, Kennedy T, Jones R, Darnley S, Chalder T.
    J Psychosom Res; 2010 Apr 03; 68(4):385-8. PubMed ID: 20307706
    [Abstract] [Full Text] [Related]

  • 9. Patients' Experiences of Telephone-Based and Web-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Longitudinal Qualitative Study.
    Hughes S, Sibelli A, Everitt HA, Moss-Morris R, Chalder T, Harvey JM, Vas Falcao A, Landau S, O'Reilly G, Windgassen S, Holland R, Little P, McCrone P, Goldsmith K, Coleman N, Logan R, Bishop FL.
    J Med Internet Res; 2020 Nov 20; 22(11):e18691. PubMed ID: 33216002
    [Abstract] [Full Text] [Related]

  • 10. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care.
    Moss-Morris R, McAlpine L, Didsbury LP, Spence MJ.
    Psychol Med; 2010 Jan 20; 40(1):85-94. PubMed ID: 19531276
    [Abstract] [Full Text] [Related]

  • 11. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J, Davis S, Ren S, Hamilton J, Scope A, Booth A, Sutton A, Parry G, Buszewicz M, Moss-Morris R, White P.
    Health Technol Assess; 2020 Sep 20; 24(46):1-490. PubMed ID: 32975190
    [Abstract] [Full Text] [Related]

  • 12. Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial.
    Everitt HA, Landau S, O'Reilly G, Sibelli A, Hughes S, Windgassen S, Holland R, Little P, McCrone P, Bishop F, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R, ACTIB trial group.
    Gut; 2019 Sep 20; 68(9):1613-1623. PubMed ID: 30971419
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
    Lackner JM, Jaccard J, Keefer L, Brenner DM, Firth RS, Gudleski GD, Hamilton FA, Katz LA, Krasner SS, Ma CX, Radziwon CD, Sitrin MD.
    Gastroenterology; 2018 Jul 20; 155(1):47-57. PubMed ID: 29702118
    [Abstract] [Full Text] [Related]

  • 15. Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility.
    Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, Holroyd K.
    Clin Gastroenterol Hepatol; 2008 Aug 20; 6(8):899-906. PubMed ID: 18524691
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome.
    McCrone P, Knapp M, Kennedy T, Seed P, Jones R, Darnley S, Chalder T.
    Eur J Gastroenterol Hepatol; 2008 Apr 20; 20(4):255-63. PubMed ID: 18334867
    [Abstract] [Full Text] [Related]

  • 17. Mediators of change in cognitive behaviour therapy and mebeverine for irritable bowel syndrome.
    Reme SE, Stahl D, Kennedy T, Jones R, Darnley S, Chalder T.
    Psychol Med; 2011 Dec 20; 41(12):2669-79. PubMed ID: 21477419
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
    Lee KJ, Kim NY, Kwon JK, Huh KC, Lee OY, Lee JS, Choi SC, Sohn CI, Myung SJ, Park HJ, Choi MK, Bak YT, Rhee PL.
    Neurogastroenterol Motil; 2011 Dec 20; 23(12):1098-104. PubMed ID: 21920001
    [Abstract] [Full Text] [Related]

  • 20. A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome.
    Darvish-Damavandi M, Nikfar S, Abdollahi M.
    World J Gastroenterol; 2010 Feb 07; 16(5):547-53. PubMed ID: 20128021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.